Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts

Cardiovascular Research

Volumn 61, Issue 3, 2004, Pages 620-629

  Van Kerckhoven, Roeland ^a   Van Veghel, Richard ^a   Saxena, Pramod R ^a   Schoemaker, Regien G ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Angiogenesis; Capillaries; Heart rate; Hypertrophy; Infarction

Indexed keywords

ACETYLSALICYLIC ACID; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LECTIN; LYSINE ACETYLSALICYLATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MOXONIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART PERFUSION; HEART RATE; HEART VENTRICLE REMODELING; IN VITRO STUDY; IN VIVO STUDY; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ASPIRIN; BLOOD PRESSURE; CAPILLARIES; CAPTOPRIL; CORONARY CIRCULATION; GLUCOCORTICOIDS; HEART RATE; HYPERTROPHY, LEFT VENTRICULAR; IMIDAZOLES; MALE; METHYLPREDNISOLONE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOM ALLOCATION; RATS; RATS, WISTAR; SYMPATHOLYTICS;

EID: 1142297591     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.09.026     Document Type: Article

References (48)

1. Anversa P., Loud A.V., Levicky V., Guideri G. Left ventricular failure induced by myocardial infarction: II. Tissue morphometry. Am. J. Physiol. 248:1985;H883-H889.
2. Sladek T., Sladkova J., Kolar F.et al. The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc. Res. 31:1996;568-576.
3. Liu Y.H., Yang X.P., Sharov V.G.et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 99:1997;1926-1935.
4. Zheng W., Brown M.D., Brock T.A., Bjercke R.J., Tomanek R.J. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ. Res. 85:1999;192-198.
5. Hudlicka O., Brown M.D., Walter H., Weiss J.B., Bate A. Factors involved in capillary growth in the heart. Mol. Cell. Biochem. 147:1995;57-68.
6. Brown M.D., Davies M.K., Hudlicka O. The effect of long-term bradycardia on heart microvascular supply and performance. Mol. Cell. Biol. Res. 40:1994;137-142.
7. Gordon R.J. A general mathematical model of coronary circulation. Am. J. Physiol. 226:1974;608-615.
8. Packer M. Pathophysiology of chronic heart failure. Lancet. 340:1992;88-92.
9. Francis G.S. Neurohumoral activation and progression of heart failure: hypothetical and clinical considerations. J. Cardiovasc. Pharmacol. 32:1998;S16-S21.
10. Fishbein M.C., Maclean D., Maroko P.R. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am. J. Pathol. 90:1978;57-70.
11. Van Kerckhoven R., van Veen T.A., Boomsma F., Saxena P.R., Schoemaker R.G. Chronic administration of moxonidine suppresses sympathetic activation in a rat heart failure model. Eur. J. Pharmacol. 397:2000;113-120.
12. Schoemaker R.G., Debets J.J., Struyker-Boudier H.A., Smits J.F. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J. Mol. Cell. Cardiol. 23:1991;187-197.
13. Van Kerckhoven R., Kalkman E.A., Saxena P.R., Schoemaker R.G. Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts. Cardiovasc. Res. 46:2000;316-323.
14. Schoemaker R.G., Saxena P.R., Kalkman E.A. Low-dose aspirin improves in vivo hemodynamics in conscious, chronically infarcted rats. Cardiovasc. Res. 37:1998;108-114.
15. Kalkman E.A., Bilgin Y.M., van Haren P., van Suylen R.J., Saxena P.R., Schoemaker R.G. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc. Res. 32:1996;1088-1095.
16. Nelissen-Vrancken H.J., Kuizinga M.C., Daemen M.J., Smits J.F. Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts. Cardiovasc. Res. 40:1998;156-164.
17. Kalkman E.A., van Suylen R.J., van Dijk J.P., Saxena P.R., Schoemaker R.G. Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat. J. Mol. Cell. Cardiol. 27:1995;2483-2494.
18. Patrignani P., Filabozzi P., Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Invest. 69:1982;1366-1372.
19. Pfeffer J.M., Pfeffer M.A., Braunwald E. Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation. 75:1987;I149-I155.
20. Kalkman E.A., van Haren P., Saxena P.R., Schoemaker R.G. Regionally different vascular response to vasoactive substances in the remodelled infarcted rat heart; aberrant vasculature in the infarct scar. J. Mol. Cell. Cardiol. 29:1997;1487-1497.
21. Schoemaker R.G., Kalkman E.A., Smits J.F. 'Quality of life' after therapy in rats with myocardial infarction: dissociation between hemodynamic and behavioral improvement. Eur. J. Pharmacol. 298:1996;17-25.
22. Benjamin I.J., Jalil J.E., Tan L.B., Cho K., Weber K.T., Clark W.A. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ. Res. 65:1989;657-670.
23. Gerdes A.M., Callas G., Kasten F.H. Differences in regional capillary distribution and myocyte sizes in normal and hypertrophic rat hearts. Am. J. Anat. 156:1979;523-531.
24. Batra S., Rakusan K. Capillary length, tortuosity, and spacing in rat myocardium during cardiac cycle. Am. J. Physiol. 263:1992;H1369-H1376.
25. Pfeffer M.A., Pfeffer J.M., Fishbein M.C.et al. Myocardial infarct size and ventricular function in rats. Circ. Res. 44:1979;503-512.
26. Wallenstein S., Zucker C.L., Fleiss J.L. Some statistical methods useful in circulation research. Circ. Res. 47:1980;1-9.
27. Lindenfeld J., Robertson A.D., Lowes B.D., Bristow M.R. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers. J. Am. Coll. Cardiol. 38:2001;1950-1956.
28. Ziegler D., Haxhiu M.A., Kaan E.C., Papp J.G., Ernsberger P. Pharmacology of moxonidine, an I1-imidazoline receptor agonist. J. Cardiovasc. Pharmacol. 27:1996;S26-S37.
29. Motz W., Scheler S., Mox B. The potential clinical application of moxonidine in congestive heart failure. Rev. Contemp. Pharmacother. 9:1998;473-479.
30. Negrao C.E., Moreira E.D., Santos M.C., Farah V.M., Krieger E.M. Vagal function impairment after exercise training. J. Appl. Physiol. 72:1992;1749-1753.
31. Schoemaker R.G., van Heijningen C.L. Bradykinin mediates cardiac preconditioning at a distance. Am. J. Physiol. Heart Circ. Physiol. 278:2000;H1571-H1576.
32. Courtney K.R., Colwell W.T., Jensen R.A. Prostaglandins and pacemaker activity in isolated guinea pig SA node. Prostaglandins. 16:1978;451-459.
33. Hedqvist P. Basic mechanisms of prostaglandin action on autonomic neurotransmission. Annu. Rev. Pharmacol. Toxicol. 17:1977;259-279.
34. Haynes D.R., Wright P.F., Gadd S.J., Whitehouse M.W., Vernon-Roberts B. Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites? Agents Actions. 39:1993;49-58.
35. Kohl P., Noble D. Mechanosensitive connective tissue: potential influence on heart rhythm. Cardiovasc. Res. 32:1996;62-68.
36. Volders P.G., Daemen M.J. Interstitial fibrosis and angiotensin- converting enzyme inhibition in patients with end-stage myocardial infarction. J. Am. Coll. Cardiol. 32:1998;552-553.
37. Harmsen E., Schoemaker R., Yu J., Ruzicka M., Leenen F.H. Sensitivity to ischaemic ATP breakdown in different models of cardiac hypertrophy in rats. J. Hypertens. 12:1994;49-57.
38. Turek Z., Grandtner M., Kubat K., Ringnalda B.E., Kreuzer F. Arterial blood gases, muscle fiber diameter and intercapillary distance in cardiac hypertrophy of rats with an old myocardial infarction. Pflugers Arch. 376:1978;209-215.
39. Anversa P., Beghi C., Kikkawa Y., Olivetti G. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ. Res. 58:1986;26-37.
40. Wright A.J., Hudlicka O. Capillary growth and changes in heart performance induced by chronic bradycardial pacing in the rabbit. Circ. Res. 49:1981;469-478.
41. Granetzny A., Schwanke U., Schmitz C.et al. Pharmacologic heart rate reduction: effect of a novel, specific bradycardic agent on the heart. Thorac. Cardiovasc. Surg. 46:1998;63-69.
42. Stewart J.T., Simpson I.A., Smith R.E., Callicott C., Gray H.H., Camm A.J. Left ventricular energetics: heat production by the human heart. Cardiovasc. Res. 27:1993;1024-1032.
43. Xie Z., Gao M., Horimoto M., Togashi H., Saito H., Koyama T. Rearrangement of the ventricular capillary network in stroke-prone spontaneously hypertensive rats (SHRSP) following a late start of treatment with the angiotensin converting enzyme blocker temocapril. Jpn. Heart J. 39:1998;699-706.
44. Tharp G.D., Wagner C.T. Chronic exercise and cardiac vascularization. Eur. J. Appl. Physiol. Occup. Physiol. 48:1982;97-104.
45. Gao M. Arterialization of the capillary network in the left ventricular subendocardium in young rats subjected to exercise training. Hokkaido Igaku Zasshi. 72:1997;225-234.
46. Areskog N.H. Effects and adverse effects of autonomic blockade in physical exercise. Am. J. Cardiol. 55:1985;132D-134D.
47. White F.C., McKirnan M.D., Breisch E.A., Guth B.D., Liu Y.M., Bloor C.M. Adaptation of the left ventricle to exercise-induced hypertrophy. J. Appl. Physiol. 62:1987;1097-1110.
48. Baffour R., Achanta K., Kaufman J.et al. Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury. J. Neurosurg. 83:1995;105-110.